發送短信 : Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial

  ____       ___     _    _      ___              
 |  _ \\    / _ \\  | || | ||   / _ \\    ____    
 | |_| ||  / //\ \\ | || | ||  | / \ ||  |    \\  
 | .  //  |  ___  ||| \\_/ ||  | \_/ ||  | [] ||  
 |_|\_\\  |_||  |_|| \____//    \___//   |  __//  
 `-` --`  `-`   `-`   `---`     `---`    |_|`-`   
                                         `-`